We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Impacts of micro- and nanoplastics on early-life health: a roadmap towards risk assessment
AI summary Read the abstract
Researchers proposed a detailed risk assessment roadmap specifically for how micro- and nanoplastic exposure during pregnancy and early childhood could harm fetal and infant development, noting that these tiny particles have already been detected in human placentas. The framework identifies critical gaps in dosing data, detection methods, and placental transfer research needed before reliable safety conclusions can be drawn.
Abstract Micro- and nanoplastics (MNPs) are ubiquitous environmental pollutants representing a concern for human health. MNPs have been detected in human placentas, indicating that during pregnancy maternal exposure may lead to placental transfer and foetal exposure, with potential for adverse effects on early-life development. However, a comprehensive risk assessment (RA) framework, specific to early-life is lacking. Here, we propose a novel roadmap to assist the development of an early-life health RA of MNPs. This roadmap is designed based on established chemical, mixture, particle, and MNP assessment strategies aligned with standard RA components (problem formulation, hazard identification, hazard characterisation, exposure assessment, risk characterisation). We systematically work through these stages to identify what is needed to progress a RA for the early-life impacts of MNPs, including what information is missing, and what may be used in the interim. While challenges such as complex physicochemical properties of MNPs, limited toxicity data at relevant exposure levels, and uncertainties related to characterising complex exposures have been described elsewhere, our work discusses how these challenges specifically impact early-life stages such as the significance of MNP presence in biological samples and factors influencing bioaccumulation and placental transfer. Additionally, we introduce the development of new technology readiness levels for methods used in the detection of MNPs in complex matrices. Importantly, this review integrates a broad scope of relevant information into one comprehensive document, providing a unified resource. We highlight specific requirements and areas for targeted research, including the development of dose-response relationships specific to early-life stages and novel strategies for assessing bioaccumulation and placental transfer of MNPs. By addressing these gaps, our roadmap aims to advance the development of a robust framework, ultimately enhancing the understanding and mitigation of risks associated with early-life exposure to MNPs.
More Papers Like This
Micro- and Nanoplastics and Fetal Health: Challenges in Assessment and Evidence from Epidemiological Studies
AI summary Read the abstract
This review examines the emerging evidence that micro- and nanoplastics can reach the developing fetus during pregnancy, with animal studies showing potential effects on neurological development and placental blood flow. The study also highlights major challenges in accurately detecting and measuring these tiny particles in biological tissues from mothers and babies. The authors call for standardized methods and more human studies to better understand the risks of prenatal microplastic exposure.
Towards a risk assessment framework for micro- and nanoplastic particles for human health
AI summary Read the abstract
This review proposes a framework for assessing the health risks of micro- and nanoplastics to humans, noting that current methods are inadequate because these particles come in countless types, sizes, and chemical compositions. The authors recommend focusing first on inhalation risks and suggest using existing approaches for evaluating low-toxicity particles and fibers as a starting point for plastic particle safety standards.
Paradigms to assess the human health risks of nano- and microplastics
AI summary Read the abstract
Researchers proposed a new, comprehensive framework for assessing the health risks of nano- and microplastics (tiny plastic particles), addressing key gaps in how we analyze these particles, model their behavior, and use that information to protect human health — since no such standard risk assessment system currently exists.
Bridging the Gaps between Microplastics and Human Health
AI summary Read the abstract
This review synthesizes evidence on how humans are exposed to microplastics and nanoplastics through inhalation, ingestion, breastmilk, skin contact, and placental transfer, and surveys animal and in vitro studies showing that these particles can cross the placental barrier and disrupt fetal development. The authors highlight that nanoplastics — even smaller and more bioavailable than microplastics — remain severely understudied despite their likely greater toxicity. They call for large-scale epidemiological studies and standardized measurement methods to close the major gaps between what lab studies suggest and what we actually know about human health impacts.
A Children’s Health Perspective on Nano- and Microplastics
AI summary Read the abstract
Researchers examined the toxic effects of polyethylene and polypropylene microplastics on the marine copepod Acartia tonsa across multiple life stages, finding that nauplii were significantly more sensitive than adult copepods. The study demonstrates the importance of testing vulnerable early life stages when establishing environmental quality standards for microplastic contamination.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.